カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

世界のハイスループットスクリーニング市場（～2028年）：製品別（機器、消耗品、サービス）、技術別（セルベースアッセイ、ラボオンチップ、ラベルフリー）、用途別（創薬、生命科学研究）、エンドユーザー別（製薬、バイオテクノロジー、CRO）

■ 英語タイトル：High Throughput Screening Market by Product (Instrument, Consumable, Service), Technology (Cell-based Assays, Lab-on-a-Chip, Label-free), Application (Drug Discovery, Life Sciences Research), End User (Pharma, Biotech, CRO) - Global Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：BT2220-23）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：BT2220-23
■ 発行日：2023年7月5日
■ 調査対象地域：グローバル
■ 産業分野：バイオ
■ ページ数：356
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥742,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥997,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,222,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のハイスループットスクリーニング市場（～2028年）：製品別（機器、消耗品、サービス）、技術別（セルベースアッセイ、ラボオンチップ、ラベルフリー）、用途別（創薬、生命科学研究）、エンドユーザー別（製薬、バイオテクノロジー、CRO）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

MarketsandMarkets社は、世界のハイスループットスクリーニング市場規模が2023年の256億ドルから、2028年には445億ドルに達すると予測しています。また、予想期間中、年平均成長率は11.6%を記録する見通しです。本書では、ハイスループットスクリーニングの世界市場について調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（消耗品、機器、サービス、ソフトウェア）分析、技術別（セルベースアッセイ、ラボオンチップ、ラベルフリー）分析、用途別（創薬、生化学スクリーニング、生命科学研究、その他）分析、エンドユーザー別（製薬・バイオテクノロジー、学術・研究機関、CRO（受託研究機関）、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などの項目を記載しています。並びに、市場調査の対象企業には、Thermo Fisher Scientific,Inc. (US)、Agilent Technologies,Inc. (US)、Merck KGaA (Germany)、Danaher Corporation (US) 、PerkinElmer,Inc. (US)、Tecan Group Ltd. (Switzerland)、A256億AM S.p.A (Italy)、Promega Corporation (US)などが該当します。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のハイスループットスクリーニング市場規模：製品別
- 消耗品の市場規模
- 機器の市場規模
- サービスの市場規模
- ソフトウェアの市場規模
・世界のハイスループットスクリーニング市場規模：技術別
- セルベースアッセイ技術における市場規模
- ラボオンチップ技術における市場規模
- ラベルフリー技術における市場規模
・世界のハイスループットスクリーニング市場規模：用途別
- 創薬における市場規模
- 生化学スクリーニングにおける市場規模
- 生命科学研究における市場規模
- その他用途における市場規模
・世界のハイスループットスクリーニング市場規模：エンドユーザー別
- 製薬・バイオテクノロジーにおける市場規模
- 学術・研究機関における市場規模
- CRO（受託研究機関）における市場規模
- その他エンドユーザーにおける市場規模
・世界のハイスループットスクリーニング市場規模：地域別
- 北米のハイスループットスクリーニング市場規模
- ヨーロッパのハイスループットスクリーニング市場規模
- アジア太平洋のハイスループットスクリーニング市場規模
- 中南米のハイスループットスクリーニング市場規模
- 中東・アフリカのハイスループットスクリーニング市場規模
・競争状況
・企業情報

“The global high-throughput screening market size is projected to reach USD 44.5 billion by 2028 from USD 25.6 billion in 2023, at a CAGR of 11.6% during the forecast period.”
Increase in government funding and venture capital investments is one of the high impact drivers of the high throughput screening market. In March 2023, Iktos, a company specializing in artificial intelligence for new drug discovery, today announces the closing of a 15.5 million euros (USD 16 Mn) Series A financing co-led by new investors M Ventures and Debiopharm Innovation Fund with participation from Omnes Capital. This financing will enable the company to further develop its AI and drug discovery capabilities and expand its existing SaaS software offering, in addition to launching Iktos Robotics.

“The services segment is set to register highest growth rate during 2023-2028 in HTS market”
The high-throughput screening market is segmented into consumables, instruments, , services, and software. HTS services have emerged as a lucrative market space, with fastest growth in the market registered through the forecast period. Routine adoption of outsourcing of HTS services by pharmaceutical companies, including lead identification, screening, toxicology, and other preclinical studies contributes to the segment growth.

“CRO end user segment is set to witness the highest growth rate in the HTS market”
Based on end user , the high-throughput screening market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs) and other end users. The key factor driving the growth of this segment includes trend of outsourcing of R&D activities by pharmaceutical and biotechnology companies. In recent years, due to the enormous pressure to contain fixed costs, outsourcing has evolved as a strategic alternative for pharmaceutical & biopharmaceutical companies due to the lack of in-house resources required for new product development and the need for cost & time savings.
 
“Drug Discovery segment accounted for the highest CAGR”
Based on application , the high-throughput screening market is segmented into drug discovery, biochemical screening, life sciences research and other applications. The drug discovery segment is set to grow at the fastest pace throughout 2023 to 2028. The key factor driving this segment’s growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure. Continuous advancements in HTS technologies, such as automation, miniaturization, and high-content screening, are impacting the growth of the segment. Automation enables the handling and screening of large compound libraries with high precision and throughput, improving efficiency and reducing costs.

“Asia Pacific: The fastest-growing country in the high-throughput screening market”
The high-throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America, and the MEA. Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the HTS market in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Supply side- 80%, Demand side-20%
• By Designation: C-level – 45%, D-level – 30%, and Others – 25%
• By Region: Asia-Pacific -55%, North America -20%, Europe -10%, Latin America-10%, Middle East and Africa-5%

Lists of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc. (US)
• Agilent Technologies, Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• PerkinElmer, Inc. (US)
• Tecan Group Ltd. (Switzerland)
• AXXAM S.p.A (Italy)
• Promega Corporation (US)
• Bio-Rad Laboratories, Inc.(US)
• Promega Corporation (US)
• Hamilton Company (US)
• Corning Incorporated (US)
• Charles River Laboratories (US)
• Lonza (Switzerland)
• REPROCELL Inc. (Japan)
• Aurora Biomed (Canada)
• BMG LABTECH (Germany)
• DIANA Biotechnologies, s.r.o. (Czech Republic)
• NanoTemper Technologies GmbH (Germany)
• Creative Biolabs (US)
• Biomat Srl (Italy)

Research Coverage:
This report provides a detailed picture of the high throughput screening market. It aims at estimating the size and future growth potential of the market across different segments, such as the product & service, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Analysis of key drivers (the growing adoption of open innovative models in pharmaceutical & biotechnology companies, government funding and venture capital investments, increasing R&D spending, and technological advancements), restraints (high costs of using HTS instruments, and complexities in assay development), oppotunities (increasing adoption of HTS technologies in emerging markets, and growing applications in stem cell research), and challenges (dearth of skilled operators, and complexities in data analysis and management) influencing the growth of the HTS market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the HTS market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various high-throughput screening across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high-throughput screening market.
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players like Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), PerkinElmer, Inc. (US), among others in the high-throughput screening market.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION 50
1.1 STUDY OBJECTIVES 50
1.2 MARKET DEFINITION 50
1.2.1 INCLUSIONS AND EXCLUSIONS 50
1.3 MARKET SCOPE 51
FIGURE 1 HTS MARKET SEGMENTATION 51
1.3.1 YEARS CONSIDERED 52
1.3.2 CURRENCY CONSIDERED 52
1.4 LIMITATIONS 52
1.5 STAKEHOLDERS 53
1.6 SUMMARY OF CHANGES 53
1.6.1 RECESSION IMPACT 54
2 RESEARCH METHODOLOGY 55
2.1 RESEARCH DATA 55
FIGURE 2 RESEARCH DESIGN 55
2.1.1 SECONDARY DATA 56
2.1.2 PRIMARY DATA 56
FIGURE 3 HTS MARKET: BREAKDOWN OF PRIMARIES 57
2.2 MARKET SIZE ESTIMATION 58
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 58
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 59
FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE SHARE ANALYSIS, 2022 59
2.2.1 INSIGHTS FROM PRIMARIES 60
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS 60
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 61
2.3 GROWTH FORECAST 62
FIGURE 9 HTS MARKET: CAGR PROJECTIONS, 2023–2028 62
FIGURE 10 HTS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 63
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 64
FIGURE 11 DATA TRIANGULATION METHODOLOGY 64
2.5 RESEARCH ASSUMPTIONS 65
2.6 RISK ANALYSIS 65
2.7 RECESSION IMPACT ANALYSIS 65
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 66
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 66
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 66
3 EXECUTIVE SUMMARY 67
FIGURE 12 HTS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 67
FIGURE 13 HTS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 68
FIGURE 14 HTS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 68
FIGURE 15 HTS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 69
FIGURE 16 GEOGRAPHICAL SNAPSHOT: HTS MARKET 69
4 PREMIUM INSIGHTS 71
4.1 HIGH-THROUGHPUT SCREENING MARKET OVERVIEW 71
FIGURE 17 GROWING ADOPTION OF OPEN INNOVATIVE MODELS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH 71
4.2 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022) 72
FIGURE 18 CONSUMABLES DOMINATED NORTH AMERICAN HTS MARKET IN 2022 72
4.3 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 73
FIGURE 19 CONSUMABLES TO CONTINUE TO DOMINATE MARKET BY 2028 73
4.4 HIGH-THROUGHPUT SCREENING MARKET SHARE, BY END USER, 2022 73
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 73
4.5 HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 74
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
FIGURE 22 HTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 75
TABLE 4 HTS MARKET: IMPACT ANALYSIS 76
5.2.1 DRIVERS 76
5.2.1.1 Growing adoption of open innovation models in pharmaceutical & biotechnology companies 76
5.2.1.2 Government funding and venture capital investments 77
TABLE 5 INVESTMENT BREAKDOWN, 2021 (USD MILLION) 78
5.2.1.3 Increasing R&D spending 78
FIGURE 23 RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 79
5.2.1.4 Technological advancements 79
5.2.2 RESTRAINTS 80
5.2.2.1 High cost of using screening instruments 80
TABLE 6 INSTRUMENT PRICING (USD) 81
5.2.2.2 Complexities in assay development 81
5.2.3 OPPORTUNITIES 82
5.2.3.1 Increasing adoption of screening technologies in emerging economies 82
5.2.3.2 Growing applications in stem cell research 82
5.2.4 CHALLENGES 83
5.2.4.1 Dearth of skilled operators 83
5.2.4.2 Complexities in data analysis and management 83
5.3 TECHNOLOGY ANALYSIS 84
TABLE 7 TECHNOLOGY ANALYSIS 84
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 85
FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR HTS SOLUTIONS PROVIDERS 86
5.5 PRICING ANALYSIS 86
5.5.1 AVERAGE SELLING PRICES OF KEY PLAYERS (GLOBAL) 86
TABLE 8 AVERAGE SELLING PRICES 86
5.5.2 AVERAGE SELLING PRICE TREND 86
5.6 VALUE CHAIN ANALYSIS 87
FIGURE 25 MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE 87
5.7 SUPPLY CHAIN ANALYSIS 88
FIGURE 26 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES 89
5.8 ECOSYSTEM ANALYSIS 89
FIGURE 27 ECOSYSTEM ANALYSIS: HTS MARKET 89
TABLE 9 OVERALL MARKET ECOSYSTEM FOR HTS 90
5.9 PATENT ANALYSIS 91
FIGURE 28 HTS MARKET: PATENT GRANTED (JANUARY 2013–MAY 2023) 91
5.10 REGULATORY ANALYSIS 92
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 13 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.11 PORTER’S FIVE FORCES ANALYSIS 96
TABLE 14 HTS MARKET: PORTER’S FIVE FORCES ANALYSIS 96
5.11.1 THREAT OF NEW ENTRANTS 96
5.11.2 THREAT OF SUBSTITUTES 96
5.11.3 BARGAINING POWER OF BUYERS 96
5.11.4 BARGAINING POWER OF SUPPLIERS 97
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 97
5.12 KEY CONFERENCES & EVENTS IN 2022–2023 97
TABLE 15 HTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 97
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 98
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 98
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HTS TECHNOLOGIES 98
5.13.2 BUYING CRITERIA FOR DRUG DISCOVERY SERVICES 99
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 99
6 HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE 100
6.1 INTRODUCTION 101
TABLE 16 HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 101
6.2 CONSUMABLES 101
TABLE 17 HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 18 HTS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 19 NORTH AMERICA: HTS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 20 EUROPE: HTS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 21 ASIA PACIFIC: HTS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 22 LATIN AMERICA: HTS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.2.1 REAGENTS & ASSAY KITS 103
6.2.1.1 Wide applications in life sciences research to support demand for consumables 103
TABLE 23 HTS REAGENTS & ASSAY KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 24 NORTH AMERICA: HTS REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 25 EUROPE: HTS REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 26 ASIA PACIFIC: HTS REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 27 LATIN AMERICA: HTS REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
6.2.2 LABORATORY EQUIPMENT 105
6.2.2.1 Development of high-quality equipment to drive market 105
TABLE 28 HTS LABORATORY EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 29 NORTH AMERICA: HTS LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 30 EUROPE: HTS LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 31 ASIA PACIFIC: HTS LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 32 LATIN AMERICA: HTS LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.3 INSTRUMENTS 107
TABLE 33 HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 34 HTS INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 35 NORTH AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 36 EUROPE: HTS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 37 ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 38 LATIN AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.3.1 LIQUID HANDLING SYSTEMS 110
6.3.1.1 Increased innovation and automation to drive market 110
TABLE 39 HTS LIQUID HANDLING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 40 NORTH AMERICA: HTS LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 41 EUROPE: HTS LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 42 ASIA PACIFIC: HTS LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 43 LATIN AMERICA: HTS LIQUID HANDLING SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
6.3.2 DETECTION SYSTEMS 112
6.3.2.1 Demand for high-throughput capabilities to support growth 112
TABLE 44 HTS DETECTION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 45 NORTH AMERICA: HTS DETECTION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 46 EUROPE: HTS DETECTION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 47 ASIA PACIFIC: HTS DETECTION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 48 LATIN AMERICA: HTS DETECTION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
6.3.3 OTHER INSTRUMENTS 114
TABLE 49 HTS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 115
TABLE 50 NORTH AMERICA: HTS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 51 EUROPE: HTS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 52 ASIA PACIFIC: HTS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 53 LATIN AMERICA: HTS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 116
6.4 SERVICES 116
6.4.1 NEED FOR COST OPTIMIZATION AND ACCESS TO SPECIALIZED EXPERTISE TO BOOST DEMAND 116
TABLE 54 HTS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 55 NORTH AMERICA: HTS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 56 EUROPE: HTS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 57 ASIA PACIFIC: HTS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 58 LATIN AMERICA: HTS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
6.5 SOFTWARE 119
6.5.1 RISING AUTOMATION AND AVAILABILITY OF ROBUST DATA MANAGEMENT SOFTWARE TOOLS TO DRIVE MARKET 119
TABLE 59 HTS SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 60 NORTH AMERICA: HTS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 61 EUROPE: HTS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 62 ASIA PACIFIC: HTS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 63 LATIN AMERICA: HTS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
7 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY 122
7.1 INTRODUCTION 123
TABLE 64 HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 123
7.2 CELL-BASED ASSAYS 123
TABLE 65 COMPARISON OF 2D AND 3D CELL CULTURE 124
TABLE 66 HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 67 HTS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 68 NORTH AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 69 EUROPE: HTS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 70 ASIA PACIFIC: HTS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 71 LATIN AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 126
7.2.1 2D CELL CULTURE 126
TABLE 72 HTS MARKET FOR 2D CELL CULTURE, BY REGION, 2021–2028 (USD MILLION) 127
TABLE 73 NORTH AMERICA: HTS MARKET FOR 2D CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 74 EUROPE: HTS MARKET FOR 2D CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 75 ASIA PACIFIC: HTS MARKET FOR 2D CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 76 LATIN AMERICA: HTS MARKET FOR 2D CELL CULTURE BY COUNTRY, 2021–2028 (USD MILLION) 128
7.2.2 3D CELL CULTURE 128
TABLE 77 HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 78 HTS MARKET FOR 3D CELL CULTURE, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 79 NORTH AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 80 EUROPE: HTS MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 81 ASIA PACIFIC: HTS MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 82 LATIN AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 130
7.2.2.1 Scaffold-based technology 131
TABLE 83 HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 84 HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION) 132
TABLE 85 NORTH AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 86 EUROPE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 87 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 88 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 133
7.2.2.1.1 Hydrogels 133
TABLE 89 HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 90 HTS MARKET FOR HYDROGELS, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 91 NORTH AMERICA: HTS MARKET FOR HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 92 EUROPE: HTS MARKET FOR HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 93 ASIA PACIFIC: HTS MARKET FOR HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 94 LATIN AMERICA: HTS MARKET FOR HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 136
7.2.2.1.1.1 Animal-derived hydrogels 136
TABLE 95 HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 96 HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY REGION, 2021–2028 (USD MILLION) 137
TABLE 97 NORTH AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 98 EUROPE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 99 ASIA PACIFIC: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 100 LATIN AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 138
7.2.2.1.1.1.1 Matrigel 138
TABLE 101 HTS MARKET FOR MATRIGEL, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 102 NORTH AMERICA: HTS MARKET FOR MATRIGEL, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 103 EUROPE: HTS MARKET FOR MATRIGEL, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 104 ASIA PACIFIC: HTS MARKET FOR MATRIGEL, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 105 LATIN AMERICA: HTS MARKET FOR MATRIGEL, BY COUNTRY, 2021–2028 (USD MILLION) 140
7.2.2.1.1.1.2 Collagen 140
TABLE 106 HTS MARKET FOR COLLAGEN, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 107 NORTH AMERICA: HTS MARKET FOR COLLAGEN, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 108 EUROPE: HTS MARKET FOR COLLAGEN, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 109 ASIA PACIFIC: HTS MARKET FOR COLLAGEN, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 110 LATIN AMERICA: HTS MARKET FOR COLLAGEN, BY COUNTRY, 2021–2028 (USD MILLION) 142
7.2.2.1.1.2 Synthetic hydrogels 142
TABLE 111 HTS MARKET FOR SYNTHETIC HYDROGELS, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 112 NORTH AMERICA: HTS MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 113 EUROPE: HTS MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 114 ASIA PACIFIC: HTS MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 115 LATIN AMERICA: HTS MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2021–2028 (USD MILLION) 144
7.2.2.1.1.3 Alginate/Agarose 144
TABLE 116 HTS MARKET FOR ALGINATE/AGAROSE, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 117 NORTH AMERICA: HTS MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 118 EUROPE: HTS MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 119 ASIA PACIFIC: HTS MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 120 LATIN AMERICA: HTS MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2021–2028 (USD MILLION) 146
7.2.2.1.2 Inert matrix/Solid scaffolds 146
TABLE 121 HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY REGION, 2021–2028 (USD MILLION) 147
TABLE 122 NORTH AMERICA: HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 123 EUROPE: HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 124 ASIA PACIFIC: HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 125 LATIN AMERICA: HTS MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY COUNTRY, 2021–2028 (USD MILLION) 148
7.2.2.1.3 Micropatterned surfaces 148
TABLE 126 HTS MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2021–2028 (USD MILLION) 149
TABLE 127 NORTH AMERICA: HTS MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 128 EUROPE: HTS MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 129 ASIA PACIFIC: HTS MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 130 LATIN AMERICA: HTS MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2021–2028 (USD MILLION) 150
7.2.2.2 Scaffold-free technology 150
TABLE 131 HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 132 HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION) 151
TABLE 133 NORTH AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 134 EUROPE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 135 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 136 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 152
7.2.2.2.1 Ultra-low binding plates 153
TABLE 137 HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY REGION, 2021–2028 (USD MILLION) 153
TABLE 138 NORTH AMERICA: HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 139 EUROPE: HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 140 ASIA PACIFIC: HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 141 LATIN AMERICA: HTS MARKET FOR ULTRA-LOW BINDING PLATES, BY COUNTRY, 2021–2028 (USD MILLION) 155
7.2.2.2.2 Hanging-drop plates 155
TABLE 142 HTS MARKET FOR HANGING-DROP PLATES, BY REGION, 2021–2028 (USD MILLION) 155
TABLE 143 NORTH AMERICA: HTS MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 144 EUROPE: HTS MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 145 ASIA PACIFIC: HTS MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 146 LATIN AMERICA: HTS MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2021–2028 (USD MILLION) 157
7.2.2.2.3 Other scaffold-free technologies 157
TABLE 147 HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 158
TABLE 148 NORTH AMERICA: HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 149 EUROPE: HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 150 ASIA PACIFIC: HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 151 LATIN AMERICA: HTS MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 159
7.2.3 REPORTER-BASED ASSAYS 159
TABLE 152 HTS MARKET FOR REPORTER-BASED ASSAYS, BY REGION, 2021–2028 (USD MILLION) 160
TABLE 153 NORTH AMERICA: HTS MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 154 EUROPE: HTS MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 155 ASIA PACIFIC: HTS MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 156 LATIN AMERICA: HTS MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 161
7.2.4 PERFUSION CELL CULTURE 161
TABLE 157 HTS MARKET FOR PERFUSION CELL CULTURE, BY REGION, 2021–2028 (USD MILLION) 162
TABLE 158 NORTH AMERICA: HTS MARKET FOR PERFUSION CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 159 EUROPE: HTS MARKET FOR PERFUSION CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 160 ASIA PACIFIC: HTS MARKET FOR PERFUSION CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 161 LATIN AMERICA: HTS MARKET FOR PERFUSION CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION) 163
7.3 LAB-ON-A-CHIP TECHNOLOGY 164
TABLE 162 HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION) 164
TABLE 163 NORTH AMERICA: HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 164 EUROPE: HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 165 ASIA PACIFIC: HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 166 LATIN AMERICA: HTS MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 165
7.4 LABEL-FREE TECHNOLOGY 166
TABLE 167 HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY REGION, 2021–2028 (USD MILLION) 166
TABLE 168 NORTH AMERICA: HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 169 EUROPE: HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 170 ASIA PACIFIC: HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 171 LATIN AMERICA: HTS MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 167
8 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION 168
8.1 INTRODUCTION 169
TABLE 172 HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169
8.2 DRUG DISCOVERY 169
8.2.1 DEMAND FOR EFFICIENT AND EFFECTIVE METHODS TO IDENTIFY AND DEVELOP DRUG CANDIDATES TO DRIVE MARKET 169
TABLE 173 HTS MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION) 170
TABLE 174 NORTH AMERICA: HTS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 175 EUROPE: HTS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 176 ASIA PACIFIC: HTS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 177 LATIN AMERICA: HTS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 171
8.3 BIOCHEMICAL SCREENING 172
8.3.1 GROWING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO DRIVE MARKET 172
TABLE 178 HTS MARKET FOR BIOCHEMICAL SCREENING, BY REGION, 2021–2028 (USD MILLION) 172
TABLE 179 NORTH AMERICA: HTS MARKET FOR BIOCHEMICAL SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 180 EUROPE: HTS MARKET FOR BIOCHEMICAL SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 181 ASIA PACIFIC: HTS MARKET FOR BIOCHEMICAL SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 182 LATIN AMERICA: HTS MARKET FOR BIOCHEMICAL SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 173
8.4 LIFE SCIENCES RESEARCH 174
8.4.1 INCREASING INVESTMENTS IN STEM CELL RESEARCH AND STUDY OF INFECTIOUS DISEASES TO DRIVE MARKET 174
TABLE 183 HTS MARKET FOR LIFE SCIENCES RESEARCH, BY REGION, 2021–2028 (USD MILLION) 175
TABLE 184 NORTH AMERICA: HTS MARKET FOR LIFE SCIENCES RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 185 EUROPE: HTS MARKET FOR LIFE SCIENCES RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 186 ASIA PACIFIC: HTS MARKET FOR LIFE SCIENCES RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 187 LATIN AMERICA: HTS MARKET FOR LIFE SCIENCES RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 176
8.5 OTHER APPLICATIONS 176
TABLE 188 HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 177
TABLE 189 NORTH AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 190 EUROPE: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 191 ASIA PACIFIC: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 192 LATIN AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 178
9 HIGH-THROUGHPUT SCREENING MARKET, BY END USER 179
9.1 INTRODUCTION 180
TABLE 193 HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 180
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 180
9.2.1 DEMAND FOR MINIATURIZED SCREENING SOLUTIONS IN LEAD DISCOVERY TO SUPPORT MARKET GROWTH 180
TABLE 194 HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 181
TABLE 195 NORTH AMERICA: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 196 EUROPE: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 197 ASIA PACIFIC: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 198 LATIN AMERICA: HTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 182
9.3 ACADEMIC & RESEARCH INSTITUTES 182
9.3.1 ADOPTION OF HIGH-THROUGHPUT SCREENING IN COLLABORATIVE RESEARCH TO DRIVE MARKET 182
TABLE 199 HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 183
TABLE 200 NORTH AMERICA: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 201 EUROPE: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 202 ASIA PACIFIC: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 203 LATIN AMERICA: HTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 184
9.4 CONTRACT RESEARCH ORGANIZATIONS 185
9.4.1 INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET 185
TABLE 204 HTS MARKET FOR CROS, BY REGION, 2021–2028 (USD MILLION) 185
TABLE 205 NORTH AMERICA: HTS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 206 EUROPE: HTS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 207 ASIA PACIFIC: HTS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 208 LATIN AMERICA: HTS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 187
9.5 OTHER END USERS 187
TABLE 209 HTS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 187
TABLE 210 NORTH AMERICA: HTS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 211 EUROPE: HTS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 212 ASIA PACIFIC: HTS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 213 LATIN AMERICA: HTS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 189
10 HIGH-THROUGHPUT SCREENING MARKET, BY REGION 190
10.1 INTRODUCTION 191
TABLE 214 HTS MARKET, BY REGION, 2021–2028 (USD MILLION) 191
10.2 NORTH AMERICA 191
10.2.1 NORTH AMERICA: RECESSION IMPACT 192
FIGURE 31 NORTH AMERICA: HTS MARKET SNAPSHOT 193
TABLE 215 NORTH AMERICA: HTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 216 NORTH AMERICA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 194
TABLE 217 NORTH AMERICA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 218 NORTH AMERICA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 219 NORTH AMERICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 195
TABLE 220 NORTH AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 221 NORTH AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 222 NORTH AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 223 NORTH AMERICA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 224 NORTH AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 225 NORTH AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 226 NORTH AMERICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 197
TABLE 227 NORTH AMERICA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 197
10.2.2 US 198
10.2.2.1 US to dominate market in North America 198
TABLE 228 US: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 198
TABLE 229 US: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 230 US: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 231 US: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 199
TABLE 232 US: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 233 US: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 234 US: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 235 US: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 236 US: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 237 US: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 238 US: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 201
TABLE 239 US: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 202
10.2.3 CANADA 202
10.2.3.1 Government initiatives to promote research and support market growth 202
TABLE 240 CANADA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 203
TABLE 241 CANADA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 242 CANADA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 243 CANADA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 204
TABLE 244 CANADA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 245 CANADA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 246 CANADA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 247 CANADA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 248 CANADA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 249 CANADA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 250 CANADA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 206
TABLE 251 CANADA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 206

10.3 EUROPE 207
10.3.1 EUROPE: RECESSION IMPACT 207
TABLE 252 EUROPE: HTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 253 EUROPE: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 208
TABLE 254 EUROPE: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 255 EUROPE: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 256 EUROPE: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 209
TABLE 257 EUROPE: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 258 EUROPE: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 259 EUROPE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 260 EUROPE: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 261 EUROPE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 262 EUROPE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 263 EUROPE: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 211
TABLE 264 EUROPE: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 212
10.3.2 GERMANY 212
10.3.2.1 Increasing research activity to favor demand for screening solutions 212
TABLE 265 GERMANY: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 213
TABLE 266 GERMANY: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 267 GERMANY: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 268 GERMANY: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 214
TABLE 269 GERMANY: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 270 GERMANY: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 271 GERMANY: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 272 GERMANY: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 273 GERMANY: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 274 GERMANY: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 275 GERMANY: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 216
TABLE 276 GERMANY: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 216
10.3.3 UK 217
10.3.3.1 Investments by pharmaceutical sponsors for drug discovery services to support market 217
FIGURE 32 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION) 217
TABLE 277 UK: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 218
TABLE 278 UK: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 279 UK: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 280 UK: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 219
TABLE 281 UK: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 282 UK: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 283 UK: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 284 UK: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 285 UK: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 286 UK: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 287 UK: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 221
TABLE 288 UK: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 221
10.3.4 FRANCE 222
10.3.4.1 Large pharmaceutical manufacturing industry to drive market 222
TABLE 289 FRANCE: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 222
TABLE 290 FRANCE: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 291 FRANCE: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 292 FRANCE: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 223
TABLE 293 FRANCE: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 294 FRANCE: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 295 FRANCE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 296 FRANCE: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 224
TABLE 297 FRANCE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 298 FRANCE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 299 FRANCE: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 225
TABLE 300 FRANCE: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 226
10.3.5 ITALY 226
10.3.5.1 Strong collaborative research networks to fuel growth 226
TABLE 301 ITALY: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 226
TABLE 302 ITALY: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 303 ITALY: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 304 ITALY: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 227
TABLE 305 ITALY: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 306 ITALY: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 307 ITALY: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 308 ITALY: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 309 ITALY: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 310 ITALY: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 311 ITALY: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 230
TABLE 312 ITALY: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 230
10.3.6 SPAIN 230
10.3.6.1 Rising R&D expenditure and increasing public-private partnerships to drive market 230
TABLE 313 SPAIN: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 231
TABLE 314 SPAIN: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 315 SPAIN: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 316 SPAIN: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 232
TABLE 317 SPAIN: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 318 SPAIN: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 319 SPAIN: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 320 SPAIN: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 321 SPAIN: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 322 SPAIN: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 323 SPAIN: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 234
TABLE 324 SPAIN: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 234
10.3.7 REST OF EUROPE 235
TABLE 325 REST OF EUROPE: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 235
TABLE 326 REST OF EUROPE: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 327 REST OF EUROPE: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 328 REST OF EUROPE: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 236
TABLE 329 REST OF EUROPE: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 330 REST OF EUROPE: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 331 REST OF EUROPE: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 332 REST OF EUROPE: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 333 REST OF EUROPE: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 334 REST OF EUROPE: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 335 REST OF EUROPE: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 238
TABLE 336 REST OF EUROPE: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 239
10.4 ASIA PACIFIC 239
10.4.1 ASIA PACIFIC: RECESSION IMPACT 239
FIGURE 33 ASIA PACIFIC: HTS MARKET SNAPSHOT 240
TABLE 337 ASIA PACIFIC: HTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 241
TABLE 338 ASIA PACIFIC: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 241
TABLE 339 ASIA PACIFIC: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 340 ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 341 ASIA PACIFIC: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 242
TABLE 342 ASIA PACIFIC: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 343 ASIA PACIFIC: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 344 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 345 ASIA PACIFIC: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 346 ASIA PACIFIC: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 347 ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 348 ASIA PACIFIC: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 244
TABLE 349 ASIA PACIFIC: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 245
10.4.2 CHINA 245
10.4.2.1 Presence of key CROs to favor market growth 245
TABLE 350 CHINA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 246
TABLE 351 CHINA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 352 CHINA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 353 CHINA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 247
TABLE 354 CHINA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 355 CHINA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 356 CHINA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 357 CHINA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 358 CHINA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 359 CHINA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 360 CHINA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 249
TABLE 361 CHINA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 249
10.4.3 JAPAN 250
10.4.3.1 Rising prominence of regenerative medicine research to drive market 250
TABLE 362 JAPAN: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 250
TABLE 363 JAPAN: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 364 JAPAN: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 365 JAPAN: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 251
TABLE 366 JAPAN: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 367 JAPAN: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 368 JAPAN: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 369 JAPAN: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 370 JAPAN: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 371 JAPAN: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 372 JAPAN: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 254
TABLE 373 JAPAN: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 254
10.4.4 INDIA 254
10.4.4.1 Low-cost services and strong government support to propel market 254
TABLE 374 INDIA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 255
TABLE 375 INDIA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 376 INDIA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 377 INDIA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 256
TABLE 378 INDIA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 379 INDIA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 380 INDIA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 381 INDIA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 382 INDIA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 383 INDIA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 384 INDIA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 258
TABLE 385 INDIA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 259
10.4.5 REST OF ASIA PACIFIC 259
TABLE 386 REST OF ASIA PACIFIC: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 260
TABLE 387 REST OF ASIA PACIFIC: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 388 REST OF ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 389 REST OF ASIA PACIFIC: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 261
TABLE 390 REST OF ASIA PACIFIC: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 391 REST OF ASIA PACIFIC: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 392 REST OF ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 393 REST OF ASIA PACIFIC: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 394 REST OF ASIA PACIFIC: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 395 REST OF ASIA PACIFIC: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 396 REST OF ASIA PACIFIC: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 263
TABLE 397 REST OF ASIA PACIFIC: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 263
10.5 LATIN AMERICA 264
10.5.1 LATIN AMERICA: RECESSION IMPACT 264
TABLE 398 LATIN AMERICA: HTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 264
TABLE 399 LATIN AMERICA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 265
TABLE 400 LATIN AMERICA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 265
TABLE 401 LATIN AMERICA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 265
TABLE 402 LATIN AMERICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 266
TABLE 403 LATIN AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 404 LATIN AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 405 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 406 LATIN AMERICA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 407 LATIN AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 408 LATIN AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 409 LATIN AMERICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 268
TABLE 410 LATIN AMERICA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 268
10.5.2 BRAZIL 269
10.5.2.1 Rising research activity to contribute to growth 269
TABLE 411 BRAZIL: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 269
TABLE 412 BRAZIL: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 413 BRAZIL: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 414 BRAZIL: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 270
TABLE 415 BRAZIL: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 416 BRAZIL: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 417 BRAZIL: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 418 BRAZIL: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 419 BRAZIL: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 420 BRAZIL: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 421 BRAZIL: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 272
TABLE 422 BRAZIL: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 273
10.5.3 REST OF LATIN AMERICA 273
TABLE 423 REST OF LATIN AMERICA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 273
TABLE 424 REST OF LATIN AMERICA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 425 REST OF LATIN AMERICA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 426 REST OF LATIN AMERICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 274
TABLE 427 REST OF LATIN AMERICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 428 REST OF LATIN AMERICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 429 REST OF LATIN AMERICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 430 REST OF LATIN AMERICA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 431 REST OF LATIN AMERICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 432 REST OF LATIN AMERICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 433 REST OF LATIN AMERICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 277
TABLE 434 REST OF LATIN AMERICA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 277
10.6 MIDDLE EAST & AFRICA 277
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET 277
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 278
TABLE 435 MIDDLE EAST & AFRICA: HTS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 278
TABLE 436 MIDDLE EAST & AFRICA: HTS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 437 MIDDLE EAST & AFRICA: HTS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 438 MIDDLE EAST & AFRICA: HTS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 279
TABLE 439 MIDDLE EAST & AFRICA: HTS MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 440 MIDDLE EAST & AFRICA: HTS MARKET FOR 3D CELL CULTURE, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 441 MIDDLE EAST & AFRICA: HTS MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 442 MIDDLE EAST & AFRICA: HTS MARKET FOR HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 443 MIDDLE EAST & AFRICA: HTS MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 444 MIDDLE EAST & AFRICA: HTS MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 445 MIDDLE EAST & AFRICA: HTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 282
TABLE 446 MIDDLE EAST & AFRICA: HTS MARKET, BY END USER, 2021–2028 (USD MILLION) 282
11 COMPETITIVE LANDSCAPE 283
11.1 INTRODUCTION 283
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 284
FIGURE 34 HTS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 284
11.3 REVENUE SHARE ANALYSIS 285
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 285
11.4 MARKET SHARE ANALYSIS 286
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 286
TABLE 447 HTS MARKET: DEGREE OF COMPETITION 286
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 287
11.5.1 STARS 288
11.5.2 EMERGING LEADERS 288
11.5.3 PERVASIVE PLAYERS 288
11.5.4 PARTICIPANTS 288
FIGURE 37 HTS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 289
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 290
TABLE 448 COMPANY FOOTPRINT ANALYSIS (KEY PLAYERS) 290
TABLE 449 PRODUCT FOOTPRINT ANALYSIS (KEY PLAYERS) 291
TABLE 450 REGIONAL FOOTPRINT ANALYSIS (KEY PLAYERS) 292
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 293
11.7.1 PROGRESSIVE COMPANIES 293
11.7.2 STARTING BLOCKS 293
11.7.3 RESPONSIVE COMPANIES 293
11.7.4 DYNAMIC COMPANIES 293
FIGURE 38 HTS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 294
11.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 295
TABLE 451 HTS MARKET: DETAILED LIST OF KEY START-UPS/SMES 295
TABLE 452 HTS MARKET: COMPETITIVE BENCHMARKING OF START- UPS/SMES 296
11.9 COMPETITIVE SCENARIOS AND TRENDS 297
11.9.1 PRODUCT LAUNCHES 297
TABLE 453 HTS MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023 297
11.9.2 DEALS 298
TABLE 454 HTS MARKET: DEALS, JANUARY 2020–MAY 2023 298
11.9.3 OTHER DEVELOPMENTS 298
TABLE 455 HTS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2023 298
12 COMPANY PROFILES 299
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY COMPANIES 299
12.1.1 THERMO FISHER SCIENTIFIC, INC. 299
TABLE 456 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 299
FIGURE 39 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 300
12.1.2 AGILENT TECHNOLOGIES, INC. 305
TABLE 457 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 305
FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 306
12.1.3 MERCK KGAA 312
TABLE 458 MERCK KGAA: BUSINESS OVERVIEW 312
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022) 313
12.1.4 DANAHER CORPORATION 316
TABLE 459 DANAHER CORPORATION: BUSINESS OVERVIEW 316
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 317
12.1.1 PERKINELMER, INC. 321
TABLE 460 PERKINELMER, INC.: BUSINESS OVERVIEW 321
FIGURE 43 PERKINELMER, INC.: COMPANY SNAPSHOT (2022) 322
12.1.2 TECAN TRADING AG 326
TABLE 461 TECAN TRADING AG: BUSINESS OVERVIEW 326
FIGURE 44 TECAN TRADING AG: COMPANY SNAPSHOT (2022) 327
12.1.3 AXXAM S.P.A 330
TABLE 462 AXXAM S.P.A: BUSINESS OVERVIEW 330
12.1.4 BIO-RAD LABORATORIES, INC. 333
TABLE 463 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 333
FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 334
12.1.5 PROMEGA CORPORATION 337
TABLE 464 PROMEGA CORPORATION: BUSINESS OVERVIEW 337
12.1.6 CORNING INCORPORATED 339
TABLE 465 CORNING INCORPORATED: BUSINESS OVERVIEW 339
FIGURE 46 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 340
12.1.7 CHARLES RIVER LABORATORIES 342
TABLE 466 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW 342
FIGURE 47 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) 343
12.1.8 EUROFINS SCIENTIFIC 345
TABLE 467 EUROFINS SCIENTIFIC COMPANY: BUSINESS OVERVIEW 345
FIGURE 48 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022) 345
12.1.9 HAMILTON COMPANY 348
TABLE 468 HAMILTON COMPANY: BUSINESS OVERVIEW 348
12.1.10 LONZA 351
TABLE 469 LONZA: BUSINESS OVERVIEW 351
FIGURE 49 LONZA: COMPANY SNAPSHOT (2022) 352
12.1.11 REPROCELL, INC. 354
TABLE 470 REPROCELL, INC.: BUSINESS OVERVIEW 354
12.1.12 AURORA BIOMED 356
TABLE 471 AURORA BIOMED: BUSINESS OVERVIEW 356
12.2 OTHER PLAYERS 357
12.2.1 BMG LABTECH 357
12.2.2 DIANA BIOTECHNOLOGIES S.R.O. 358
12.2.3 NANOTEMPER TECHNOLOGIES GMBH 358
12.2.4 CREATIVE BIOLABS 359
12.2.5 BIOMAT SRL 359
12.2.6 HIGHRES BIOSOLUTIONS 360
12.2.7 CYCLICA, INC. 361
12.2.8 CROWN BIOSCIENCE 362
12.2.9 SYGNATURE DISCOVERY 363
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 364
13.1 DISCUSSION GUIDE 364
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 370
13.3 CUSTOMIZATION OPTIONS 372
13.4 RELATED REPORTS 372
13.5 AUTHOR DETAILS 373

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の生細胞イメージング市場（〜2028年）：製品別（機器、消耗品、ソフトウェア、サービス）、用途別（細胞生物学、幹細胞、創薬）、技術別（タイムラプス顕微鏡検査法、FRET、FRAP、HCS）、エンドユーザー別（製薬、バイオテクノロジー、CRO）
  • 世界の初代細胞市場（～2028年）：種類別（造血、皮膚、肝細胞、消化管、肺、腎、心臓、筋骨格）、由来別（ヒト由来初代細胞、動物由来初代細胞）、エンドユーザー別（製薬、バイオテクノロジー、CRO、学術）、地域別
  • 世界のCRISPR市場（～2028年）：製品別（酵素、キット、ライブラリ）、サービス別（GRNA設計、細胞株エンジニアリング、スクリーニング）、用途別（創薬・開発、農業）、エンドユーザー別（製薬、バイオテクノロジー、CRO、研究機関）
  • 世界の細胞解析市場（～2028年）：製品・サービス別（消耗品、機器）、技術別（フローサイトメトリー、PCR、顕微鏡）、プロセス別（計数、生存率、増殖、相互作用、単一細胞解析）、エンドユーザー別（製薬、バイオテクノロジー）
  • ハイスループットスクリーニング（HTS）のグローバル市場：超高スループットスクリーニング、セルベースアッセイ、ラボオンチップ、ラベルフリー技術
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BT2220-23 )"世界のハイスループットスクリーニング市場（～2028年）：製品別（機器、消耗品、サービス）、技術別（セルベースアッセイ、ラボオンチップ、ラベルフリー）、用途別（創薬、生命科学研究）、エンドユーザー別（製薬、バイオテクノロジー、CRO）" (英文：High Throughput Screening Market by Product (Instrument, Consumable, Service), Technology (Cell-based Assays, Lab-on-a-Chip, Label-free), Application (Drug Discovery, Life Sciences Research), End User (Pharma, Biotech, CRO) - Global Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。